| Mapping genomic loci implicates genes and synaptic biology in schizophrenia V Trubetskoy, AF Pardiñas, T Qi, G Panagiotaropoulou, S Awasthi, ... Nature 604 (7906), 502-508, 2022 | 1751 | 2022 |
| Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia J Tarabeux, O Kebir, J Gauthier, FF Hamdan, L Xiong, A Piton, ... Translational psychiatry 1 (11), e55-e55, 2011 | 266 | 2011 |
| Candidate genes and neuropsychological phenotypes in children with ADHD: review of association studies O Kebir, K Tabbane, S Sengupta, R Joober Journal of Psychiatry and Neuroscience 34 (2), 88-101, 2009 | 154 | 2009 |
| Salivary cortisol in early psychosis: New findings and meta-analysis B Chaumette, O Kebir, C Mam-Lam-Fook, Y Morvan, J Bourgin, BP Godsil, ... Psychoneuroendocrinology 63, 262-270, 2016 | 108 | 2016 |
| Neuropsychological endophenotypes in attention-deficit/hyperactivity disorder: a review of genetic association studies O Kebir, R Joober European archives of psychiatry and clinical neuroscience 261, 583-594, 2011 | 98 | 2011 |
| CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta‐analysis A Benyamina, O Kebir, L Blecha, M Reynaud, MO Krebs Addiction biology 16 (1), 1-6, 2011 | 94 | 2011 |
| Methylomic changes during conversion to psychosis O Kebir, B Chaumette, F Rivollier, F Miozzo, LP Lemieux Perreault, ... Molecular psychiatry 22 (4), 512-518, 2017 | 92 | 2017 |
| Perinatal exposure to environmental endocrine disruptors in the emergence of neurodevelopmental psychiatric diseases: a systematic review F Rivollier, MO Krebs, O Kebir International Journal of Environmental Research and Public Health 16 (8), 1318, 2019 | 66 | 2019 |
| Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders MO Krebs, O Kebir, TM Jay European Journal of Pain 23 (7), 1225-1233, 2019 | 65 | 2019 |
| Association of Disrupted in Schizophrenia 1 (DISC1) missense variants with ultra-resistant schizophrenia F Mouaffak, O Kebir, M Chayet, S Tordjman, MN Vacheron, B Millet, ... The pharmacogenomics journal 11 (4), 267-273, 2011 | 65 | 2011 |
| Dysregulated lipid metabolism precedes onset of psychosis AM Dickens, P Sen, MJ Kempton, N Barrantes-Vidal, C Iyegbe, ... Biological psychiatry 89 (3), 288-297, 2021 | 64 | 2021 |
| Altered semantic but not phonological verbal fluency in young help-seeking individuals with ultra high risk of psychosis E Magaud, O Kebir, A Gut, D Willard, F Chauchot, JP Olie, M Kazes, ... Schizophrenia research 123 (1), 53-58, 2010 | 63 | 2010 |
| Naltrexone in the treatment of broadly defined behavioral addictions: a review and meta-analysis of randomized controlled trials F Mouaffak, C Leite, S Hamzaoui, A Benyamina, X Laqueille, O Kebir European Addiction Research 23 (4), 204-210, 2017 | 61 | 2017 |
| Alpha-lipoic acid in the treatment of psychiatric and neurological disorders: a systematic review CNS de Sousa, CMG da Silva Leite, I da Silva Medeiros, LC Vasconcelos, ... Metabolic brain disease 34, 39-52, 2019 | 55 | 2019 |
| Neuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophrenia J Matricon, A Bellon, H Frieling, O Kebir, G Le Pen, F Beuvon, ... PLoS One 5 (4), e10291, 2010 | 53 | 2010 |
| Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates MA Gorsane, O Kebir, G Hache, L Blecha, HJ Aubin, M Reynaud, ... Substance abuse 33 (4), 336-349, 2012 | 50 | 2012 |
| Self-perceived cognitive functioning does not correlate with objective measures of cognition in schizophrenia I Johnson, K Tabbane, L Dellagi, O Kebir Comprehensive psychiatry 52 (6), 688-692, 2011 | 47 | 2011 |
| Hypothèse épigénétique de la schizophrénie: revue de la littérature F Rivollier, L Lotersztajn, B Chaumette, MO Krebs, O Kebir L'encephale 40 (5), 380-386, 2014 | 45 | 2014 |
| Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia F Sauvanaud, O Kebir, M Vlasie, V Doste, I Amado, MO Krebs L'encephale 43 (3), 235-240, 2016 | 39* | 2016 |
| Altered cortical processing of motor inhibition in schizophrenia PG Lindberg, M Térémetz, S Charron, O Kebir, A Saby, N Bendjemaa, ... Cortex 85, 1-12, 2016 | 38 | 2016 |
Boris ChaumetteUniversité Paris Cité, INSERM U1266, GHU Paris (France), McGill University (Canada)Adresse e-mail validée de inserm.fr